Send Press Release To Your Friends

PR Title:	GlaxoSmithKline provides update on divestment of non-core over-the-counter (OTC) brands
PR Summary:	In February 2011 GSK announced its intention to divest non-core Consumer Healthcare OTC products predominantly in the United States and Europe with aggregate annual sales of approximately £500 million. The proposed divestment is designed to realise value for shareholders and simplify GSK’s Consumer Healthcare business and allow it to focus on its priority brands and markets.

	Basic Information
	Your Name* Your Email* Friend's Name Friend's Email 1* 2   3   Your Message